Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
* ****** $KNDI Kandi's First Three Pure Electric American Prototypes in Transit https://globenewswire.com/news-release/2018/07/02/1532434/0/en/Kandi-s-First-Three-Pure-Electric-American-Prototypes-in-Transit.html
* ****** $KNDI Kandi's First Three Pure Electric American Prototypes in Transit https://globenewswire.com/news-release/2018/07/02/1532434/0/en/Kandi-s-First-Three-Pure-Electric-American-Prototypes-in-Transit.html
$MJNA @ TheStreet. Blake Schroeder, CEO of Kannaway, describing his company's beauty line as an "entry way" product for new markets and more acceptable by the mainstream consumer.
Beauty "went from something we didn't talk about at all at in the company to this becoming a significant part of our sales," says Schroeder in an interview with Real Money. "As we continue to expand, this is a product that we can lead with that's going to have less regulatory issues than other cannabis-based products."
Last year, the beauty line represented less than 5% of Kannaway's business, until the company decided to refocus. The beauty segment shot up to almost 11% of the company's sales.
San Diego-based Kannaway, has six beauty products derived from cannabis, including a detox soak, a toner, serum and an exfoliant. It launched its first beauty product only 2.5 years ago and is fast becoming one of the early movers in the European space.
Kannaway is owned by a publicly listed company Medical Marijuana Inc. $MJNA , whose stock price didn't rise above $1 over the past five years.
https://realmoney.thestreet.com/articles/07/18/2018/bath-bombs-and-muscle-creams-how-beauty-becoming-fast-lane-cannabis-growth
$MJNA @ TheStreet. Blake Schroeder, CEO of Kannaway, describing his company's beauty line as an "entry way" product for new markets and more acceptable by the mainstream consumer.
Beauty "went from something we didn't talk about at all at in the company to this becoming a significant part of our sales," says Schroeder in an interview with Real Money. "As we continue to expand, this is a product that we can lead with that's going to have less regulatory issues than other cannabis-based products."
Last year, the beauty line represented less than 5% of Kannaway's business, until the company decided to refocus. The beauty segment shot up to almost 11% of the company's sales.
San Diego-based Kannaway, has six beauty products derived from cannabis, including a detox soak, a toner, serum and an exfoliant. It launched its first beauty product only 2.5 years ago and is fast becoming one of the early movers in the European space.
Kannaway is owned by a publicly listed company Medical Marijuana Inc. $MJNA , whose stock price didn't rise above $1 over the past five years.
https://realmoney.thestreet.com/articles/07/18/2018/bath-bombs-and-muscle-creams-how-beauty-becoming-fast-lane-cannabis-growth
Kandi JV Nasdaq 'KNDI' Company Expands Efforts to Attract Renewable Energy Industry Talent https://globenewswire.com/news-release/2017/09/29/1134892/0/en/Kandi-JV-Company-Expands-Efforts-to-Attract-Renewable-Energy-Industry-Talent.html
Kandi JV Nasdaq 'KNDI' Company Expands Efforts to Attract Renewable Energy Industry Talent https://globenewswire.com/news-release/2017/09/29/1134892/0/en/Kandi-JV-Company-Expands-Efforts-to-Attract-Renewable-Energy-Industry-Talent.html
$HEMP Hemp, Inc. Creation of Proprietary Industrial Hemp Strains as U.S. Senate Supports Cannabis Seed Bank https://globenewswire.com/news-release/2018/05/31/1514851/0/en/Hemp-Inc-Announces-Creation-of-Proprietary-Industrial-Hemp-Strains-as-U-S-Senate-Supports-Cannabis-Seed-Bank.html
$HEMP Hemp, Inc. Creation of Proprietary Industrial Hemp Strains as U.S. Senate Supports Cannabis Seed Bank https://globenewswire.com/news-release/2018/05/31/1514851/0/en/Hemp-Inc-Announces-Creation-of-Proprietary-Industrial-Hemp-Strains-as-U-S-Senate-Supports-Cannabis-Seed-Bank.html
$HEMP Hemp, Inc. Applauds Illinois as Industrial Hemp Bill Now Awaits Governor's Signature http://hempinc.com/hemp-inc-applauds-illinois-as-industrial-hemp-bill-now-awaits-governors-signature/
$HEMP Hemp, Inc. Applauds Illinois as Industrial Hemp Bill Now Awaits Governor's Signature http://hempinc.com/hemp-inc-applauds-illinois-as-industrial-hemp-bill-now-awaits-governors-signature/
$HEMP Hemp, Inc.'s Strategic Hemp Growing Partner, “Veteran Village Kins Community Arizona, Inc.”, Completes Solar Energy System Installation as Arizona Legalizes Industrial Hemp http://hempinc.com/hemp-inc-strategic-hemp-growing-partner-veteran-village-kins-community-arizona-inc-receives-coverage-by-the-kingman-daily-miner-for-veteran-focused-cultivation-plan/
$HEMP Hemp, Inc.'s Strategic Hemp Growing Partner, “Veteran Village Kins Community Arizona, Inc.”, Completes Solar Energy System Installation as Arizona Legalizes Industrial Hemp http://hempinc.com/hemp-inc-strategic-hemp-growing-partner-veteran-village-kins-community-arizona-inc-receives-coverage-by-the-kingman-daily-miner-for-veteran-focused-cultivation-plan/
$HEMP Hemp, Inc. Applauds Missouri Legislature for Passing Industrial Hemp Bill http://hempinc.com/hemp-inc-applauds-missouri-legislature-for-passing-industrial-hemp-bill/
$KNDI Thomson Reuters/Verus resumed coverage for KANDI TECHNOLGIES GROUP INC with a HOLD recommendation.
$KNDI Thomson Reuters/Verus resumed coverage for KANDI TECHNOLGIES GROUP INC with a HOLD recommendation.
**** $INSY Insys Therapeutics - its proprietary intranasal formulation of epinephrine to treat anaphylaxis achieved plasma absorption similar to that of Mylan's (MYL) Epipen.
Janney analyst Ken Trbovich said in a note to clients on Friday morning that Insys management told him the formulation achieved plasma levels in excess of 100 picograms per milliliter in less than five minutes.
"This is important because the FDA sees this as a critical threshold to establish a therapeutic benefit," Trbovich said. "Others who have attempted to deliver epinephrine via the intranasal route have failed to reach the 100 pg/ml level in less than 5 minutes. The company also noted its study ensured absorption was not significantly impaired by those suffering from nasal congestion and it did so by showing similar results."
Insys shares jumped 15% in pre-bell trading.
Epinephrine has been around for more than 100 years, but the current market is dominated by autoinjectors because they can deliver the drug rapidly.
Insys management told Janney that it plans to meet with the Food & Drug Administration to discuss the results and find a path forward before the end of the year. That likely indicates that a new drug application will be filed no later than the first half of 2019, with a potential for a priority review. If that happens, the drug could be approved by the first quarter of 2020.
Insys has filed a patent application for its proprietary intranasal spray formulation, which relies on caprylic acid and a second permeation enhancer to enable rapid plasma absorption intranasally. Based on the patent application date, if issued, the patent would be in effect at least through 2035 and perhaps as along as 2037.
"Insys also believes its formulation can offer longer shelf-life, which is another potential advantage easily overlooked by investors," Trbovich said. "Epinephrine degrades at room temperatures resulting in lower potency of the product over time."
**** $INSY Insys Therapeutics - its proprietary intranasal formulation of epinephrine to treat anaphylaxis achieved plasma absorption similar to that of Mylan's (MYL) Epipen.
Janney analyst Ken Trbovich said in a note to clients on Friday morning that Insys management told him the formulation achieved plasma levels in excess of 100 picograms per milliliter in less than five minutes.
"This is important because the FDA sees this as a critical threshold to establish a therapeutic benefit," Trbovich said. "Others who have attempted to deliver epinephrine via the intranasal route have failed to reach the 100 pg/ml level in less than 5 minutes. The company also noted its study ensured absorption was not significantly impaired by those suffering from nasal congestion and it did so by showing similar results."
Insys shares jumped 15% in pre-bell trading.
Epinephrine has been around for more than 100 years, but the current market is dominated by autoinjectors because they can deliver the drug rapidly.
Insys management told Janney that it plans to meet with the Food & Drug Administration to discuss the results and find a path forward before the end of the year. That likely indicates that a new drug application will be filed no later than the first half of 2019, with a potential for a priority review. If that happens, the drug could be approved by the first quarter of 2020.
Insys has filed a patent application for its proprietary intranasal spray formulation, which relies on caprylic acid and a second permeation enhancer to enable rapid plasma absorption intranasally. Based on the patent application date, if issued, the patent would be in effect at least through 2035 and perhaps as along as 2037.
"Insys also believes its formulation can offer longer shelf-life, which is another potential advantage easily overlooked by investors," Trbovich said. "Epinephrine degrades at room temperatures resulting in lower potency of the product over time."
**** $INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to Mylan's Epipen $MYL *******
**** $INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to Mylan's Epipen $MYL *******
$INSY Zacks Investment Research, Inc. upgrades INSYS THERAPEUTICS INC from SELL to HOLD.
$INSY Zacks Investment Research, Inc. upgrades INSYS THERAPEUTICS INC from SELL to HOLD.
$HEMP Hemp, Inc. Applauds Senate Agriculture Committee for Passing Farm Bill with Hemp Legalization https://globenewswire.com/news-release/2018/06/20/1527021/0/en/Hemp-Inc-Applauds-Senate-Agriculture-Committee-for-Passing-Farm-Bill-with-Hemp-Legalization.html
$HEMP Hemp, Inc. Applauds Senate Agriculture Committee for Passing Farm Bill with Hemp Legalization https://globenewswire.com/news-release/2018/06/20/1527021/0/en/Hemp-Inc-Applauds-Senate-Agriculture-Committee-for-Passing-Farm-Bill-with-Hemp-Legalization.html
$Hemp Hemp, Inc. Describes Booming Opportunity for Hemp in The Denmark News Coverage of Wisconsin’s Newest Industry https://marijuanastocks.com/hemp-describes-booming-opportunity-for-hemp-in-the-denmark-news-coverage/
$Hemp Hemp, Inc. Describes Booming Opportunity for Hemp in The Denmark News Coverage of Wisconsin’s Newest Industry https://marijuanastocks.com/hemp-describes-booming-opportunity-for-hemp-in-the-denmark-news-coverage/
$HEMP Hemp, Inc. Expands Joint Venture Agreement with HQ Global Education, Inc. to Plant 50 Acres of Hemp in Spring Hope, North Carolina https://forextv.com/top-news/hemp-inc-expands-joint-venture-agreement-with-hq-global-education-inc-to-plant-50-acres-of-hemp-in-spring-hope-north-carolina/
$HEMP Hemp, Inc. Expands Joint Venture Agreement with HQ Global Education, Inc. to Plant 50 Acres of Hemp in Spring Hope, North Carolina https://forextv.com/top-news/hemp-inc-expands-joint-venture-agreement-with-hq-global-education-inc-to-plant-50-acres-of-hemp-in-spring-hope-north-carolina/
$HEMP Hemp, Inc. Commends U.S. Senate for Passing Farm Bill with Hemp Legalization After Decades of Prohibition http://globenewswire.com/news-release/2018/06/29/1531670/0/en/Hemp-Inc-Commends-U-S-Senate-for-Passing-Farm-Bill-with-Hemp-Legalization-After-Decades-of-Prohibition.html
$HEMP Hemp, Inc. Commends U.S. Senate for Passing Farm Bill with Hemp Legalization After Decades of Prohibition http://globenewswire.com/news-release/2018/06/29/1531670/0/en/Hemp-Inc-Commends-U-S-Senate-for-Passing-Farm-Bill-with-Hemp-Legalization-After-Decades-of-Prohibition.html
$HEMP Hemp, Inc. Praises U.S. Senate for Supporting Military Veterans’ Access to Medical Cannabis as Company Ramps Up Veteran Hemp Growing Initiatives http://markets.businessinsider.com/news/stocks/hemp-inc-praises-u-s-senate-for-supporting-military-veterans-access-to-medical-cannabis-as-company-ramps-up-veteran-hemp-growing-initiatives-1027344443
$HEMP Hemp, Inc. Praises U.S. Senate for Supporting Military Veterans’ Access to Medical Cannabis as Company Ramps Up Veteran Hemp Growing Initiatives http://markets.businessinsider.com/news/stocks/hemp-inc-praises-u-s-senate-for-supporting-military-veterans-access-to-medical-cannabis-as-company-ramps-up-veteran-hemp-growing-initiatives-1027344443
$HEMP Hemp, Inc. Launches National Tour to Expand Industrial Hemp Growing Capacity in the United States http://hempinc.com/hemp-inc-launches-national-tour-to-expand-industrial-hemp-growing-capacity-in-the-united-states/
$HEMP Hemp, Inc. Launches National Tour to Expand Industrial Hemp Growing Capacity in the United States http://hempinc.com/hemp-inc-launches-national-tour-to-expand-industrial-hemp-growing-capacity-in-the-united-states/
$HEMP Hemp, Inc. Expertise and Product Offering Featured in The Business Journal's Coverage of Emerging Hemp Marketplace
https://globenewswire.com/news-release/2018/07/17/1538462/0/en/Hemp-Inc-Expertise-and-Product-Offering-Featured-in-The-Business-Journal-s-Coverage-of-Emerging-Hemp-Marketplace.html
$HEMP Hemp, Inc. Expertise and Product Offering Featured in The Business Journal's Coverage of Emerging Hemp Marketplace
https://globenewswire.com/news-release/2018/07/17/1538462/0/en/Hemp-Inc-Expertise-and-Product-Offering-Featured-in-The-Business-Journal-s-Coverage-of-Emerging-Hemp-Marketplace.html
$MJNA Medical Marijuana, Inc. Begins Efforts to Enter Canadian Cannabis Market
https://www.medicalmarijuanainc.com/medical-marijuana-inc-begins-efforts-to-enter-canadian-cannabis-market/
$MJNA Medical Marijuana, Inc. Begins Efforts to Enter Canadian Cannabis Market
https://www.medicalmarijuanainc.com/medical-marijuana-inc-begins-efforts-to-enter-canadian-cannabis-market/
$MJNA Forbes Covers Medical Marijuana, Inc. Subsidiary HempMeds® Mexico's Recent International Expansion, Interviews HempMeds® Latin America President https://www.medicalmarijuanainc.com/forbes-covers-medical-marijuana-inc-subsidiary-hempmeds-mexicos-recent-international-expansion-interviews-hempmeds-latin-america-president/
$MJNA Forbes Covers Medical Marijuana, Inc. Subsidiary HempMeds® Mexico's Recent International Expansion, Interviews HempMeds® Latin America President https://www.medicalmarijuanainc.com/forbes-covers-medical-marijuana-inc-subsidiary-hempmeds-mexicos-recent-international-expansion-interviews-hempmeds-latin-america-president/
$MJNA Medical Marijuana, Inc. Subsidiary Kannaway® Announces New THC-Free CBD Hemp Oil for Pets
https://www.medicalmarijuanainc.com/medical-marijuana-inc-subsidiary-kannaway-announces-new-thc-free-cbd-hemp-oil-for-pets/